MeiraGTx Holdings plc Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $1.29M.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $54.00K, a 88.70% decline year-over-year.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $219.00K.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $141.00K, a 19.43% decline year-over-year.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for fiscal 2021 was $1.71M, a 103.21% increase from fiscal 2020.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for fiscal 2020 was $841.00K, a 50.82% increase from fiscal 2019.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for fiscal 2019 was $557.61K.
- MeiraGTx Holdings plc stock issued during period, value, stock options exercised for fiscal 2017 was $9.95K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $1.29M derived: 10-K 12 month − 3 quarters · filed 2022-03-10 | $1.71M 10-K · filed 2022-03-10 |
| 2021-09-30 | $54.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $219.00K 10-Q · filed 2021-11-10 | |
| 2021-03-31 | $141.00K 10-Q · filed 2021-11-10 | |
| 2020-12-31 | $841.00K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $478.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $175.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $557.61K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $53.34K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $1.27K 10-Q · filed 2020-11-05 | |
| 2017-12-31 | $9.95K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |